Abbott, Thomas A.; Vernon, John A. - In: Managerial and Decision Economics 28 (2007) 4-5, pp. 293-306
Previous empirical studies that have examined the links between pharmaceutical price controls, profits, cash flows, and investment in research and development (R&D) have been largely based on retrospective statistical analyses of firm- and|or industry-level data. These studies, which have...
